Regulatory News: GeNeuro (Euronext Paris : CH0308403085 – GNRO), société biopharmaceutique développant de nouveaux traitements pour les maladies neurodégénératives et auto-immunes, telles que la...
Regulatory News: GeNeuro SA (Paris:GNRO) and GILBERT DUPONT have terminated the liquidity contract entered into on March 6, 2021. This termination took effect on June 30, 2024, after market...
Market: Euronext Paris ISIN code / Mnemo: CH0308403085 / GNRO Web site: www.geneuro.com Regulatory News: Pursuant to the liquidity contract entrusted by GENEURO SA (Paris:GNRO) to Gilbert Dupont...
Regulatory News: GeNeuro (Euronext Paris: CH0308403085 – GNRO): L'essai clinique GNC-501 est une étude de phase 2 chez des patients souffrant de syndromes neuropsychiatriques post-COVID-19...
81,54% du capital social de la société était représenté à l'assemblée générale et les résolutions ont toutes été approuvées à l’unanimité Regulatory News: GeNeuro (Euronext Paris : CH0308403085...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.004 | -5.78034682081 | 0.0692 | 0.078 | 0.065 | 34671 | 0.06878411 | DE |
4 | 0.0032 | 5.16129032258 | 0.062 | 0.0876 | 0.062 | 23247 | 0.0728387 | DE |
12 | -1.6298 | -96.1533923304 | 1.695 | 1.99 | 0.0558 | 114780 | 0.15904699 | DE |
26 | -1.2148 | -94.90625 | 1.28 | 2.35 | 0.0558 | 56742 | 0.34655632 | DE |
52 | -1.4848 | -95.7935483871 | 1.55 | 2.35 | 0.0558 | 32241 | 0.48690995 | DE |
156 | -3.5548 | -98.1988950276 | 3.62 | 4.24 | 0.0558 | 13702 | 1.0166568 | DE |
260 | -3.7948 | -98.310880829 | 3.86 | 6.28 | 0.0558 | 10781 | 1.69539165 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.